Scumaci Robert F

Avg. Two Year Performance

No purchase track record
20% Avg. Sale Return
10% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return< 1%8%9%11%20%
Sale Success Rate3 of 43 of 43 of 43 of 43 of 4

Sepracor, Inc.

Drugs » Drug Manufacturers - Other

EVP & Chief Financial Officer:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--